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Relationship Between Delayed Pain Flares, Psychogenic Stress 
and Free Thyroxine in Patients with Phantom Limb Pain
INTRODUCTION
Phantom limb pain (PLP) involves a variety of painful and
debilitating sensations following amputation that are
perceived to originate from a limb, or limb segment, that is
no longer connected to the body.1 PLP is a common problem
for individuals following an amputation, occurring in 42 to
78% of cases,1 with severe pain reported in 5 to 10% of
cases.2 Individuals can experience PLP as feelings of
stabbing, cramping, burning, clenching, muscle spasms,
tingling, and/or paralyzing sensations.3 While there is no
agreement as to the etiology of PLP, current theories involve
neuropathic changes, either distally or via central nervous
system remodeling.4 As such, PLP may be considered a
form of neuropathic pain and may be potentially modulated
by factors that have been established to influence the
frequency and/or level of pain experienced in other
neuropathicconditions.
Previous studies have found a ten-day delay in the onset of
perceived pain flares following stressful events in patients
with other neuropathic pain syndromes including
fibromyalgia syndrome (FS),5 complex regional pain
syndrome (CRPS),6 and migraine headaches.7 Using serial
lag correlations, these studies found low correlations
between stressful events and same day pain. The largest
relationship found was between levels for stress and
perceived pain intensity occurring ten days later. 8 This is
consistent with the established behavior of thyroxine;
following secretion it is bound and enters a period of latency
for approximately ten days at which point it is released in a
metabolically active form that elicits systemic effects.9 A
study involving patients with CRPS provided support for the
hypothesis that the stress-related hormone thyroxine may be
responsible for the up-regulation of neural pain pathways
ten days after its release during stressful events.6 It is
hypothesized that episodes of increased PLP may also be
subject to modulation by psychogenic stress and show a
similar latent appearance due to the psychogenic release of
thyroxine.8
Figure 1. Stress-related release of thyroxine and resulting hormone cascade 
leading to increased perceived intensity of neuropathic pain 10 days 
following the stressor. 6
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If it is established that PLP episodes also appear ten days 
after salient stressors, this information can be used by 
people with amputations and their medical caregivers alike 
to help understand the etiology of painful episodes, predict 
and plan for their occurrences, and distinguish between 
stress-related episodes and those brought on by other life 
activities.
PURPOSE
The purpose of this study was to investigate the temporal
relationship between psychogenic stress, stress-related
thyroid hormone activity, and the frequency and severity of
potentially latent phantom limb pain episodes. Specifically,
this study aims to determine whether PLP responds to
thyroxine in the same manner as other established
neuropathic pain conditions. If the same stress-thyroxine-
pain relationship is observed, it would suggest that
thyroxine is not acting at the local tissue level and rather
acts at the level of the central or peripheral nervous system.
SUBJECTS
This is a case study design with two patient cases, both with
long-standing PLP. Participant 1 was a 44-year-old male
who had an upper extremity amputation and intact thyroid
function. Participant 2 was a 32-year-old male with a history
of lower extremity amputation and thyroidectomy which
was managed by a stable levothyroxine regimen. Neither
reported taking any medication for pain control.
METHODS
Each day, for 10 weeks, participants completed ratings of
pain and stress using visual analog scales (VAS), and daily
blood samples for FT4 analysis. VAS scores were measured
and recorded by two blinded investigators. Serum thyroxine
was assessed via a small daily blood draw performed by the
participant each evening. Blood samples were collected by
the principal investigator daily and refrigerated from the
time of collection until mailing, which was conducted on a
weekly basis. To ensure the integrity of data, blood samples
were mailed to two separate labs which independently
analyzed levels of FT4. Thyroxine values from one lab
demonstrated internal consistency errors therefore the data
from this lab was excluded from analysis.
ANALYSIS
To identify the presence of stress-related delays in both pain
flares and FT4 peaks, VAS ratings of stress were compared
to FT4 and pain using serial lag correlations of 0-14 days.
To determine the relationship between FT4 levels and
perceived pain, VAS ratings were analyzed using same-day
correlations. All statistical analysis was conducted in
Microsoft Excel.
RESULTS
Serial lag correlations between stress and pain, and stress
and FT4, demonstrated the strongest relationship on the
tenth day following a salient psychogenic stressor. The
relationship between participants’ ratings of stress and pain
ten days later is demonstrated in Figure 2 and Figure 3 for
participants 1 and 2, respectively. Correlations between
these values were r = +0.53 (p<0.001) for participant 1, and
r = -0.05 (p>0.05) for participant 2. Correlations between
ratings of stress and serum FT4 ten days later were r =
+0.74 (p<0.001) for participant 1 and r = -0.02 (p>0.05) for
participant 2. Figures 4 and 5 demonstrate the relationship
between ratings of same-day pain and thyroxine for
participants 1 and 2, respectively. Correlations between
these values were r = +0.47 (p<0.001) for participant 1 and
r = -0.02 (p>0.05) for participant 2.
DISCUSSION
This case comparison suggests that there is a relationship
between stress, thyroxine and pain flares in patients with
PLP who have an intact thyroid. Our findings with
participant 1 are consistent with previous literature, which
has illustrated a peak in reported levels of pain and FT4 ten
days following a stressful event.6 This relationship was not
observed in participant 2, who had a history of
thyroidectomy. This difference supports the hypothesis that
stress-related FT4 levels are contributing to modulation of
pain since participant 2 did not demonstrate stress-related
FT4 fluctuations due to his stable regimen of levothyroxine.
Because in PLP the local tissue in the area of perceived pain
no longer exists this indicates that thyroxine is not
modulating pain at the local tissue level and is instead
exerting its effects at the peripheral or central nervous
system level. Since participants with PLP demonstrated the
same stress-thyroxine-pain relationship that has been
observed in other neuropathic pain conditions, it could be
hypothesized that other neuropathic pain conditions are also
being modulated at the central or peripheral level by
thyroxine.
CONCLUSIONS
These findings support the hypothesis that FT4 levels
related to psychogenic stress are associated with delayed
flares in PLP, suggesting that PLP behaves in the same way
as other neuropathic pain conditions and that thyroxine acts
at the level of the central or peripheral nervous system to
upregulate pain pathways.
RELEVANCE
Patients with PLP may benefit from understanding the
relationship between stress and pain, as this information can
help them predict and plan for painful episodes. This may
also prevent them from excessively limiting their activities
to avoid increases in pain.
Figure 2.  Participant 1 visual analog stress scale (VASS) and visual 
analog pain scale (VAPS) lagged by 10 days.
Figure 3.  Participant 2 visual analog stress scale (VASS) and visual 
analog pain scale (VAPS) lagged by 10 days. 
Figure 4. Participant 1, same-day visual analog pain scores (VAPS) and 
FT4 relationship.
Figure 5. Participant 2, same-day visual analog pain scores (VAPS) and 
FT4 relationship.
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